- Home
- AZN vs UBS Comparison
AZN vs UBS Comparison
Compare AZN & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AZN | UBS |
|---|---|---|
| Founded | 1992 | 1862 |
| Country | United Kingdom | Switzerland |
| Employees | 96100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.4B | 154.1B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | AZN | UBS |
|---|---|---|
| Price | $182.97 | $47.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $60.30 |
| AVG Volume (30 Days) | 1.8M | ★ 2.1M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.73% | 1.29% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.34 | $7.40 |
| Revenue Next Year | $6.43 | $2.83 |
| P/E Ratio | $31.91 | ★ $17.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $68.62 | $30.39 |
| 52 Week High | $212.71 | $49.36 |
Technical Indicators
Market Signals| Indicator | AZN | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 47.40 | 60.59 |
| Support Level | $180.98 | $46.32 |
| Resistance Level | $191.50 | $48.90 |
| Average True Range (ATR) | 3.17 | 0.80 |
| MACD | 0.15 | -0.15 |
| Stochastic Oscillator | 50.12 | 64.94 |
Price Performance
Historical ComparisonAbout AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
About UBS UBS Group AG Registered
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.